Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-TS25-036, Identify and Evaluate Potential Risk Factors for ALS; Amended Notice of Closed Meeting, 99871 [2024-29009]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 238 / Wednesday, December 11, 2024 / Notices
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–29004 Filed 12–10–24; 8:45 am]
[FR Doc. 2024–29008 Filed 12–10–24; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
99871
Time: 10 a.m.–5 p.m., EST.
The meeting is closed to the public.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
lotter on DSK11XQN23PROD with NOTICES1
[FR Doc. 2024–29009 Filed 12–10–24; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—TS25–036,
Identify and Evaluate Potential Risk
Factors for ALS; Amended Notice of
Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention, pursuant to Public Law 92–
463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
CE25–026, Rigorously Evaluating
Programs and Policies to Prevent Child
Sexual Abuse and Problematic Sexual
Behavior among Youth.
Dates: April 29–30, 2025.
Times: 10 a.m.–5 p.m., EDT.
Place: Web Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Aisha L. Wilkes, M.P.H., Scientific
Review Officer, National Center for
Injury Prevention and Control, Centers
for Disease Control and Prevention,
4770 Buford Highway NE, Mailstop
S106–9, Atlanta, Georgia 30341.
Telephone: (404) 639–6473; Email:
AWilkes@cdc.gov.
VerDate Sep<11>2014
18:17 Dec 10, 2024
Jkt 265001
Centers for Disease Control and
Prevention, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
FOR FURTHER INFORMATION CONTACT:
Carlisha Gentles, Pharm.D., B.C.P.S.,
C.D.C.E.S., Scientific Review Officer,
National Center for Injury Prevention
and Control, Centers for Disease Control
and Prevention, 4770 Buford Highway
NE, Mailstop S106–9, Atlanta, Georgia
30341. Telephone: (770) 488–1504;
Email: CGentles@cdc.gov.
SUPPLEMENTARY INFORMATION: Notice is
hereby given of a change in the meeting
of the Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—TS25–036,
Identify and Evaluate Potential Risk
Factors for ALS; February 25–26, 2025,
10 a.m.–5 p.m., EST, web conference, in
the original Federal Register notice. The
meeting notice was published in the
Federal Register on December 2, 2024,
89 FR 95215.
This meeting notice is being amended
to change the meeting dates from a twoday meeting to a one-day meeting. The
notice should read as follows:
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
TS25–036, Identify and Evaluate
Potential Risk Factors for ALS.
Date: February 25, 2025.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10515 and
CMS–10780]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
February 10, 2025.
SUMMARY:
E:\FR\FM\11DEN1.SGM
11DEN1
]]>Agencies
[Federal Register Volume 89, Number 238 (Wednesday, December 11, 2024)]
[Notices]
[Page 99871]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-29009]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP)--TS25-036, Identify and Evaluate Potential Risk
Factors for ALS; Amended Notice of Closed Meeting
AGENCY: Centers for Disease Control and Prevention, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
FOR FURTHER INFORMATION CONTACT: Carlisha Gentles, Pharm.D., B.C.P.S.,
C.D.C.E.S., Scientific Review Officer, National Center for Injury
Prevention and Control, Centers for Disease Control and Prevention,
4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341.
Telephone: (770) 488-1504; Email: [email protected].
SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the
meeting of the Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP)--TS25-036, Identify and Evaluate Potential
Risk Factors for ALS; February 25-26, 2025, 10 a.m.-5 p.m., EST, web
conference, in the original Federal Register notice. The meeting notice
was published in the Federal Register on December 2, 2024, 89 FR 95215.
This meeting notice is being amended to change the meeting dates
from a two-day meeting to a one-day meeting. The notice should read as
follows:
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--TS25-036, Identify and Evaluate
Potential Risk Factors for ALS.
Date: February 25, 2025.
Time: 10 a.m.-5 p.m., EST.
The meeting is closed to the public.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-29009 Filed 12-10-24; 8:45 am]
BILLING CODE 4163-18-P
